Skip to content
Life Sciences Series B Founded 2015

Sensius

Developer of a hyperthermia system for cancer treatment. This system uses thermotherapy, a controlled heating process, to target tumors while preserving surrounding healthy tissue. The technology is designed to be integr

📍 Rotterdam, Netherlands · Oncology

Funding snapshot

Last roundSeries B
Amount$17M
Date19 June 2025

About

{}

Latest news

No articles yet.

Raising like Sensius?

Analyze your pitch deck before your next raise.

Analyze My Deck →